NDC 72934-2174

TACROLIMUS 0.1% IN PSEUDOCATALASE

Tacrolimus 0.1% In Pseudocatalase

TACROLIMUS 0.1% IN PSEUDOCATALASE is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Tacrolimus.

Product ID72934-2174_874b82c6-ef06-8ce2-e053-2a95a90a5695
NDC72934-2174
Product TypeHuman Prescription Drug
Proprietary NameTACROLIMUS 0.1% IN PSEUDOCATALASE
Generic NameTacrolimus 0.1% In Pseudocatalase
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameTACROLIMUS
Active Ingredient Strength0 g/100g
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2174-2

30 g in 1 BOTTLE, PUMP (72934-2174-2)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2174-2 [72934217402]

TACROLIMUS 0.1% IN PSEUDOCATALASE CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
TACROLIMUS.1 g/100g

Pharmacological Class

  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]
  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.